Wong Hing C
SEC CIK 1866258 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HCWB | HCW Biologics Inc. | CEO, Dir, 10% | 125.8K | $7.92M | — | 18 | 2021-07-22 | 2026-07-29 |
Most active insiders at HCWB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GARRETT SCOTT T | Dir | $270.0K | — |
| 2 | Wong Hing C | CEO, Dir, 10% | $220.0K | — |
| 3 | Byam Rebecca | CFO | $20.0K | — |
| 4 | Flowers Lee | SVP of Business Development | $20.0K | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 16:10 | 2026-07-29 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir, 10% | P - Purchase | $2.58 | +23.2K | 125.8K | +23% | +$60.0K | |
| D | 2026-05-27 19:26 | 2026-05-22 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir, 10% | P - Purchase | $1.41 | +113.9K | 615.8K | +23% | +$160.0K |
| 2025-05-20 | 2025-05-16 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir, 10% | P - Purchase | $7.45 | +8,054 | 501.9K | +2% | +$60.0K | |
| D | 2025-05-09 | 2025-05-08 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir, 10% | P - Purchase | $26.00 | +92.5K | 493.9K | +23% | +$2.40M |
| 2024-02-22 | 2024-02-20 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | A - Grant | $1.40 | +739.3K | 16.05M | +5% | +$1.04M | |
| 2023-09-18 | 2023-09-14 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $2.08 | +1,800 | 15.31M | +0.0% | +$3,744 | |
| M | 2023-06-02 | 2023-06-01+ | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $1.58 | +1,600 | 15.31M | +0.0% | +$2,528 |
| M | 2023-06-01 | 2023-05-30+ | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $1.55 | +5,000 | 15.31M | +0.0% | +$7,750 |
| M | 2022-09-12 | 2022-09-08+ | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $2.69 | +10.0K | 15.30M | +0.1% | +$26.9K |
| M | 2022-09-07 | 2022-09-02+ | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $2.57 | +10.0K | 15.29M | +0.1% | +$25.7K |
| 2022-06-13 | 2022-06-10 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $2.19 | +1,520 | 15.29M | +0.0% | +$3,329 | |
| M | 2022-06-09 | 2022-06-07+ | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $2.27 | +3,000 | 15.28M | +0.0% | +$6,810 |
| A | 2021-10-07 | 2021-08-27 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $3.76 | +8,000 | 15.27M | +0.1% | +$30.1K |
| A | 2021-10-07 | 2021-08-31 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $3.94 | +5,830 | 15.28M | +0.0% | +$23.0K |
| 2021-09-02 | 2021-08-31 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $3.93 | +3,830 | 15.28M | +0.0% | +$15.1K | |
| M | 2021-08-30 | 2021-08-26+ | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $3.85 | +18.5K | 15.27M | +0.1% | +$71.2K |
| D | 2021-07-23 | 2021-07-22 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | P - Purchase | $8.00 | +627.5K | 15.26M | +4% | +$5.02M |
| DM | 2021-07-23 | 2021-07-22 | HCWB | HCW Biologics Inc. | Wong Hing C | CEO, Dir | C - Cnv Deriv | $0.00 | +10.34M | 14.63M | +241% | $0 |
Purchase Sale Sale after option exercise All abbreviations